GMOV

Investor Moves

Name	Value	Action	Change	Price	Current Price
Jeremy GranthamGMO $3.4M122.5k shares AddQ1 2026 $1.6M $28.10 $30.37
Ken GriffinCitadel Advisors $-794.6K ExitQ4 2025 $795k -- $30.37
Ken GriffinCitadel Advisors $-794.6K ExitQ4 2025 $795k -- $30.37
Ken GriffinCitadel Advisors $563.1K AddQ3 2025 $563k -- $30.37
Ken GriffinCitadel Advisors $563.1K AddQ3 2025 $563k -- $30.37
Ken GriffinCitadel Advisors $-732.4K ExitQ1 2025 $732k -- $30.37

Trade GMOV

About GMO US Value ETF

GMOV's primary objective is to achieve comprehensive investment returns by focusing on undervalued American equities. The fund employs a sophisticated methodology that combines its proprietary quantitative analysis with historical market comparisons. This rigorous process evaluates companies based on crucial financial indicators, including asset valuation, cash flow generation, and their potential for future earnings. Such detailed assessment then informs strategic decisions regarding portfolio position sizes and sector allocations. Furthermore, the fund integrates specific ESG criteria, actively avoiding investments in industries like cluster munitions and thermal coal. Maintaining a strong commitment to the U.S. market, at least 80% of GMOV's assets are tied to American enterprises, potentially leading to a higher concentration in certain sectors. To ensure optimal liquidity and facilitate responsiveness to evolving market conditions, the fund has the flexibility to invest in the GMO US Treasury Fund and other short-term money market instruments.

IPO Date: Oct 29, 2024

Market Data

Open: $29.79
High: $29.97
Low: $29.62
Volume: 10.4K
Avg Volume: 14.3K
52W High: $30.57
52W Low: $24.47

Valuation

Market Cap: $91M
Dividend Yield: 60.9%

Financials

Financial statement snapshot is not available yet.

Events

DividendMar 31

$0.169